Type 1 diabetes
Coverage of Type 1 diabetes in the Nexus archive.
- Drug that delays onset of type 1 diabetes approved in England and Wales
The drug teplizumab, which delays the onset of type 1 diabetes for up to three years, has been approved for NHS use in England and Wales. It marks the first treatment of its kind and is described as a major breakthrough in diabetes care.
- Kerala Budget: Mittayi scheme for Type 1 diabetic children to get a makeover
The Kerala Budget announces reforms to the Mittayi scheme for Type 1 diabetic children, including access to quality medicines, insulin pumps, and CGM sensors. Parent organizations welcome the announcements and urge early implementation.
- STAT+: FDA approves Sanofi diabetes drug for children with stage 3 diabetes
The FDA approved Sanofi's teplizumab for children aged 8 and older with stage 3 diabetes. The drug underwent a speedy review program but the agency missed its decision deadline of April 21. Sanofi requested to withdraw the drug from the program after Tracy Beth Høeg, a former top drug regulator, disagreed with a staff approval decision.
- Insulin inhaler could become alternative for Type 1 diabetes insulin injections
A medical breakthrough is showing promise for millions of Americans with Type 1 diabetes, offering an alternative to insulin injections through an insulin inhaler. The article highlights this potential treatment method without specifying further details.
- STAT+: Scientists track cellular disruptions that lead to type 1 diabetes
Scientists have found new clues to understanding type 1 diabetes by tracking cellular disruptions in the pancreas. Two studies published in Science Translational Medicine used biosensors and genetic analyses to illuminate the pathway of beta-cell destruction. The research may lead to early detection and prevention of the disease.
- NHS rollout of artificial pancreas narrows inequality in diabetes care
The NHS rollout of artificial pancreas has improved access to treatment for people with type 1 diabetes from deprived and minority ethnic backgrounds, narrowing inequality in diabetes care. The device is a hybrid closed-loop system consisting of a sensor, algorithm, and insulin pump. This technology has been life-changing for those with type 1 diabetes.
- Scientists reverse diabetes in mice with lab-grown insulin cells
Scientists in Sweden have developed a method to create insulin-producing cells from human stem cells, which can restore blood sugar control in diabetic mice. These lab-grown cells respond strongly to glucose and were successful in transplant experiments. The breakthrough could potentially lead to a cure for type 1 diabetes.
- This cheap drug could help people with type 1 diabetes use less insulin
A clinical trial found that metformin, a low-cost drug used for type 2 diabetes, may help type 1 diabetes patients reduce insulin usage by 12% while maintaining stable blood sugar levels. The drug's mechanism was unexpected, as researchers initially aimed to address insulin resistance.